199 related articles for article (PubMed ID: 33385575)
1. Pharmacoinformatics based elucidation and designing of potential inhibitors against Plasmodium falciparum to target importin α/β mediated nuclear importation.
Oany AR; Pervin T; Moni MA
Infect Genet Evol; 2021 Mar; 88():104699. PubMed ID: 33385575
[TBL] [Abstract][Full Text] [Related]
2. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA
Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103
[TBL] [Abstract][Full Text] [Related]
3. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
[TBL] [Abstract][Full Text] [Related]
4. Exploration of new drug-like inhibitors for serine/threonine protein phosphatase 5 of Plasmodium falciparum: a docking and simulation study.
Gupta S; Jadaun A; Kumar H; Raj U; Varadwaj PK; Rao AR
J Biomol Struct Dyn; 2015; 33(11):2421-41. PubMed ID: 25967133
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
6. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
[TBL] [Abstract][Full Text] [Related]
7. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
Kesharwani RK; Singh DV; Misra K
J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
[TBL] [Abstract][Full Text] [Related]
8. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
Chaudhary M; Singh V; Anvikar AR; Sahi S
Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
[TBL] [Abstract][Full Text] [Related]
9. High throughput in silico identification and characterization of Plasmodium falciparum PRL phosphatase inhibitors.
Pandey R; Kumar R; Gupta P; Mohmmed A; Tewari R; Malhotra P; Gupta D
J Biomol Struct Dyn; 2018 Oct; 36(13):3531-3540. PubMed ID: 29039247
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.
Owoloye AJ; Ligali FC; Enejoh OA; Musa AZ; Aina O; Idowu ET; Oyebola KM
PLoS One; 2022; 17(8):e0268269. PubMed ID: 36026508
[TBL] [Abstract][Full Text] [Related]
11. An in silico strategy for identification of novel drug targets against Plasmodium falciparum.
Rout S; Patra NP; Mahapatra RK
Parasitol Res; 2017 Sep; 116(9):2539-2559. PubMed ID: 28755265
[TBL] [Abstract][Full Text] [Related]
12. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
13. Computational identification of Plasmodium falciparum RNA pseudouridylate synthase as a viable drug target, its physicochemical properties, 3D structure prediction and prediction of potential inhibitors.
Afolabi R; Chinedu S; Ajamma Y; Adam Y; Koenig R; Adebiyi E
Infect Genet Evol; 2022 Jan; 97():105194. PubMed ID: 34968763
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
Kalita J; Chetia D; Rudrapal M
Med Chem; 2020; 16(7):928-937. PubMed ID: 31385774
[TBL] [Abstract][Full Text] [Related]
15. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.
Himangini ; Pathak DP; Sharma V; Kumar S
Bioorg Med Chem Lett; 2018 May; 28(9):1566-1569. PubMed ID: 29602682
[TBL] [Abstract][Full Text] [Related]
16. Design of peptide inhibitors for the importin alpha/beta nuclear import pathway by activity-based profiling.
Kosugi S; Hasebe M; Entani T; Takayama S; Tomita M; Yanagawa H
Chem Biol; 2008 Sep; 15(9):940-9. PubMed ID: 18804031
[TBL] [Abstract][Full Text] [Related]
17. Identification of the natural compound inhibitors against
Manhas A; Kumar S; Jha PC
J Biomol Struct Dyn; 2022 Jan; 40(1):31-43. PubMed ID: 32794426
[TBL] [Abstract][Full Text] [Related]
18. Analysing the essential proteins set of Plasmodium falciparum PF3D7 for novel drug targets identification against malaria.
Ali F; Wali H; Jan S; Zia A; Aslam M; Ahmad I; Afridi SG; Shams S; Khan A
Malar J; 2021 Aug; 20(1):335. PubMed ID: 34344361
[TBL] [Abstract][Full Text] [Related]
19. Competitive Inhibition of Okanin against
Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970
[TBL] [Abstract][Full Text] [Related]
20. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
